Anne Whitaker to lead Synta Pharmaceuticals

Anne Whitaker is leaving her position of president of North America pharmaceuticals at Sanofi to take the role of president and CEO at Synta Pharmaceuticals. Synta develops small-molecule drugs for cancer and chronic inflammatory conditions, and has one candidate for nonsmall cell lung cancer in Phase III trials. Before her three-year tenure at Sanofi, Whitaker was responsible for developing and managing GlaxoSmithKline's cardiovascular and metabolic drug units.

View Full Article in:

Boston Globe (tiered subscription model), The · Wall Street Journal (tiered subscription model), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Manager, Business Conduct
Gilead
Foster City, CA
Product Patent Attorney
Gilead
Foster City, CA
Employment Counsel
Gilead
Foster City, CA
Junior to Mid-Level FDA Associate
Morgan Lewis
Washington, DC
Global Counsel - Advertising and Promotions
Mylan Inc.
Washington, DC